Stocktoria

CME GROUP INC. CME

Nasdaq · XNAS · stock · Security & Commodity Brokers, Dealers, Exchanges & Services
Chart by TradingView
4/9
Piotroski F — financial health
0.59
Altman Z″ — distress risk · distress
96.6%
Dividend payout · at-risk

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$6.5B$4.1B$4.2B$28.7B
2024$6.1B$3.5B$3.6B$26.5B
2023$5.6B$3.2B$3.4B$26.7B
2022$5.0B$2.7B$3.0B$26.9B
2021$4.7B$2.6B$2.3B$27.4B
2020$4.9B$2.1B$2.5B$26.4B

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Piell Hilda HarrisSr MD & Chief HR Officer2026-05-18Sell5,753$304.63
DUFFY TERRENCE AChairman and CEO2026-05-15Sell25,996$298.14
DUFFY TERRENCE AChairman and CEO2026-05-15Sell9,004$299.58
SHEPARD WILLIAM Rdirector2026-03-26Buy1,408$297.38
SHEPARD WILLIAM Rdirector2026-03-26Buy62$297.38
Marcus Jonathan LSr MD General Counsel2026-03-17Sell3,291$333.37
McCourt Timothy FrancisSr MD Global Head Equity & FX2026-03-15Tax withheld2,810$311.40
McCourt Timothy FrancisSr MD Global Head Equity & FX2026-03-15Grant5,504$311.40

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.59 (distress)

  • Working capital / assets 0.026
  • Retained earnings / assets 0.032
  • EBIT / assets 0.021
  • Equity / liabilities 0.169

Source: SEC EDGAR filings · CIK 0001156375 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.